RESULTS

Ascl1 redirects the fate of newborn cells
The majority of newborn cells were excitatory granule neurons 4 weeks after intrahippocampal injection of a retrovirus expressing green fluorescent protein (CAG-GFP). Most newborn cells showed the typical, highly polarized morphology of dentate granule cells and expressed the prospero-related homeobox 1 (Prox1) transcription factor and neuronal marker neuronal nuclei (NeuN, 85.7 ± 3.8%; Fig. 1 ). Only a very low number (2.5 ± 1.6%) of retrovirus-labeled cells colabeled with the oligodendrocytic marker NG2 4 weeks after virus injection, and we never observed newborn cells expressing later markers of the oligodendrocytic lineage, such as glutathione-Stransferase-p (GST-p), oligodendrocyte transcription factor 2 (Olig2), 2¢,3¢-cyclic nucleotide 3¢-phosphodiesterase (CNPase) and myelin basic protein (MBP) under control conditions ( Fig. 1c and Supplementary  Fig. 1 online) 19 .
We next sought to challenge the fate plasticity of progenitors that appear to be mainly neurogenic under normal conditions to analyze the fate potential of AHPs in vivo. Retrovirus-mediated expression of Ascl1, which has been previously described to be involved in the generation of oligodendrocytes and GABAergic interneurons [20] [21] [22] in a context-dependent manner, markedly changed the morphology of newborn cells; they no longer colabeled for Prox1 and NeuN (Fig. 1a) . Instead, cells transduced with the Ascl1-expressing retrovirus (CAG-Ascl1) exclusively colabeled with a distinct set of genes expressed in the oligodendrocytic lineage, such as NG2, GST-p and Olig2 (Fig. 1b,c) 19 . In contrast with newborn granule cells, which stay in the inner parts of the granule cell layer 23 , a number of Ascl1-overexpressing cells migrated into the hilus (Fig. 1a) , emphasizing the modified behavior of Ascl1-expressing cells compared with control cells.
Ascl1-induced cells differentiate into oligodendrocytes
Notably, a fraction of Ascl1-expressing cells showed coexpression of MBP ( Fig. 2a) and CNPase ( Supplementary Fig. 2 online) . MBP was found in the cytoplasm of Ascl1-expressing cells and in thin processes that wrapped or followed neurofilament heavy chain (NF200kd)-expressing axons (Fig. 2a-c) , suggesting that a fraction of AHP-derived oligodendrocytic cells might have the potential to myelinate 24 . Supporting a gradual maturation process of Ascl1-expressing cells, we analyzed the expression pattern of NG2 and MBP at several time points after viral injection and found a decrease in NG2 colabeling over time, whereas MBP expression increased with the age of newborn cells (percentage of coexpression with Ascl1-expressing cells at 4 d, 14 d and 4 weeks; NG2: 91.6 ± 5.7%, 78.2 ± 3.7% and 69.7 ± 5.2%; MBP: not detected, 7.1 ± 2.2% and 16.0 ± 2.1%).
To obtain independent ultrastructural evidence that Ascl1-expressing cells had indeed changed their fate, we analyzed GFPpositive cells at the electron-microscopic level using pre-embedding immunostaining and serial sectioning. We observed several morphological characteristics of oligodendrocyte or oligodendrocyte precursor cells, such as a clumpy chromatin, a large oval nucleus occupying most of the cell body, a cytoplasm lying in an eccentric position and containing numerous vesicular bodies, including a large Golgi apparatus, and several myelinated fibers in close vicinity to the cell body (Fig. 2d) . Thus, the ultrastructural characteristics, whole-cell morphology and observed switch in marker expression indicated that retroviral Ascl1 expression changed the fate of AHP progeny from a neuronal to an oligodendrocytic phenotype. Notably, Ascl1-induced oligodendrocytic cells became stably integrated into the dentate area and could be detected 3 months after virus injection (Fig. 3a) . The effect of Ascl1 overexpression on the fate of AHP progeny was also consistent between species; we found a conversion from neurogenic to oligodendrogenic AHPs in the hippocampus of adult rats (Fig. 3b) .
Ascl1-expressing virus targets neurogenic AHPs
The generation of oligodendrocytic cells occurred at the complete expense of granule cells, indicating the directed fate change of AHPs that predominantly give rise to neurons under normal conditions (Fig. 1c) . We used several independent strategies to show that AHPs that are neurogenic under control conditions indeed changed their fate with Ascl1 induction. Time course analysis showed that Ascl1-expressing and control virus-transduced AHPs were indistinguishable 24 h after virus injection (Fig. 4a,b) . We did not find any cells expressing NG2 at that time point, but the number of cells expressing the SRYrelated HMG-box gene 2 (Sox2) 25 or doublecortin (DCX) 26 did not significantly differ (P 4 0.4) between control and Ascl1-expressing cells (Fig. 4b) . However, 4 d after injection, control cells colabeled with the immature neuronal marker DCX, whereas Ascl1-expressing cells colabeled with NG2. The divergence between control and Ascl1-expressing cells became even more evident 14 d after injection; control cells extended dendritic processes into the molecular layer, whereas many Ascl1-expressing cells had migrated into the polymorphic cell layer (Fig. 4a) . We next asked whether there were differences in viral tropism between CAG-GFP and CAG-Ascl1 viruses. We co-injected CAG-Ascl1 retrovirus with RFP-expressing control virus and found that Ascl1-targeted cells were also transduced with the RFP virus (Fig. 4c) . Quantification of single-and colabeled cells showed that the relative number of cells labeled only with the RFP virus was unchanged when Ascl1-expressing virus was co-injected when compared with coinjections of GFP control virus with RFP virus ( Supplementary Fig. 3  online) . This finding suggests that the viral transduction with the Ascl1-expressing virus occurred in the same cell population that was also transduced with the RFP-expressing control virus.
We found no differences in the numbers of apoptotic cells labeled with control virus or Ascl1-expressing virus using activated caspase-3 labeling (data not shown); a rise in the number of apoptotic cells would be expected if Ascl1 expression simply killed all neurogenic cells and at the same time expanded and differentiated oligodendrocytic precursors. In addition, all Ascl1-induced cells and control cells were postmitotic 4 weeks after viral injection, as we found no coexpression of virus labeled with the cell cycle-associated protein Ki67 at this time point (data not shown). The ability of AHPs that are mostly neurogenic under normal conditions to adopt an oligodendrocytic fate with Ascl1 expression is supported by previous studies showing that oligodendrocytes and neurons can share a common progenitor, both during embryonic development and in the adult brain 14, 27 . We found it interesting that the effects of Ascl1 on neural fate decision were not dependent on Dlx gene expression 28 , as overexpression of Dlx1, Dlx2 and Dlx5 did not alter the neuronal fate of AHPs (Fig. 5 and data not shown) .
Context-dependent effects of Ascl1 expression
To analyze a potential context-dependent effect of Ascl1 (ref. 20) in the adult brain, we injected Ascl1-expressing retrovirus into the SVZ of the lateral ventricles. Although the Ascl1 promoter appears to be active in hippocampal type 2 progenitor cells 29 , we only found protein expression of Ascl1 in the adult SVZ, and not in the adult hippocampus ( Fig. 6 and data not shown) , suggesting that Ascl1 function and importance might be substantially different in the adult SVZ and in the context of neuronal differentiation of dentate granule cells. Indeed, retroviral Ascl1 expression in the SVZ did not induce a fate switch and neuronal differentiation of olfactory neurons was not substantially affected (Fig. 7a) .
We next sought to determine whether the obvious differences in Ascl1 action in the dentate gyrus and SVZ are maintained if AHPs are isolated and propagated in vitro. To this end, we isolated multipotent progenitors specifically from the dentate gyrus of adult rats (Supplementary Fig. 4 online) . In marked contrast to the in vivo effects, Ascl1 overexpression potently induced neuronal differentiation of AHPs in vitro (Tuj1, 82.3 ± 6.2%; MAP2ab, 71.8 ± 5.6%; colabeled cells) compared with AHPs labeled with a control virus (Tuj1, 2.1 ± 1.3%; MAP2ab, 1.7 ± 0.9%; P o 0.001) (Fig. 7b) , similar to the effect of Ascl1 overexpression on SVZ progenitors ( Supplementary Fig. 4 ). This finding highlights the context-dependent effects of Ascl1 and indicates that unknown local environmental clues in the adult dentate gyrus instruct AHPs to adopt an oligodendroytic fate on Ascl1 transduction.
DISCUSSION
We show here that AHPs can be instructed by expression of a single gene to differentiate into different neural fates in their in vivo niche. Thus, our data demonstrate the fate plasticity of AHPs in the adult brain.
Ascl1 is a bHLH transcription factor that has previously been implicated in the generation of oligodendrocytes and GABAergic interneurons during embryonic and early postnatal development [20] [21] [22] . Consistent with earlier studies, we found high levels of Ascl1 expression in the SVZ, suggesting that Ascl1 is involved in the generation of at least some types of olfactory neurons that are generated throughout life 20, 29 . Retrovirus-mediated Ascl1 overexpression in the SVZ did not result in substantial alterations of olfactory neurogenesis, supporting the idea that Ascl1 has a physiological role in olfactory neurogenesis. In marked contrast to findings in the SVZ, we found no substantial levels of Ascl1 protein expression in the adult hippocampus, even though the endogenous Ascl1 promoter appears to be active in distinct sets of AHPs 29 . However, Ascl1 seems to be dispensable for hippocampal granule cell development, at least during embryonic stages 30 , which is in contrast with other bHLH transcription factors, such as NeuroD1 and neurogenin-2 (refs. 30-32). Given the extensively described role for Ascl1 in oligodendrocytic development [33] [34] [35] [36] , we hypothesized that cell type-specific expression of Ascl1 in AHPs might redirect the fate of their progeny. Indeed, retrovirus-mediated expression of Ascl1 instructed AHPs to generate cells of the oligodendrocytic lineage rather than generate excitatory granule cells, which is the predominant phenotype generated under normal conditions. This effect was strongly dependent on the cellular context, as AHPs (showing unambiguous multipotency in vitro) differentiated into neuronal cells when transduced with Ascl1-expressing retrovirus in the culture dish, suggesting distinct features of AHPs in their dentate gyrus niche compared with in vitro conditions.
AHPs are multipotent in vitro 16, 18, 37, 38 , but the fate potential of AHPs remains unknown. Our data clearly show that AHPs retain the potential to switch fate even in the adult hippocampus. A recent study suggested that neural stem cells derived from the SVZ show a regionspecific diversity that is also maintained on heterotopic transplantation 39 . These findings point toward neural stem cell diversity between or even within neurogenic areas of the adult brain. However, our results show that restrictions in fate plasticity of neural stem cells in a niche are not definite and can be overcome. This finding has potential clinical relevance, as many neurological diseases, such as multiple sclerosis, stroke and epilepsy, not only affect neuronal cells, but also disrupt the functioning of other neural cell types, such as oligodendrocytes [40] [41] [42] . Thus, the finding that the fate of AHPs can be respecified by a single gene has implications for endogenous brain repair.
METHODS
Plasmids and retroviruses. Expression constructs of Ascl1 (a gift from K. Nakashima, Nara Institute of Science and Technology), Dlx1, Dlx2 and Dlx5 (gifts from J.L.R. Rubenstein, University of California, San Francisco) were subcloned into a Moloney murine leukemia retrovirus in which the expression of the transgene is driven by the compound promoter CAG, containing the CMV enhancer/chicken b-actin promoter and a large synthetic intron, as well as an IRES-GFP (a gift from I. Verma, Salk Institute of Biological Studies). Control viruses expressed GFP (CAG-GFP) or mRFP (CAG-RFP; mRFP construct was a gift from R.Y. Tsien, University of California, San Diego) under the same promoter. Retroviruses were produced as described earlier 43 and titers ranged between 2.5 and 5 Â 10 7 cfu ml -1 .
Immunostaining. Tissue and cells were fixed and processed for immunostaining as described earlier 44 . As primary antibodies, we used rabbit antibody to GFP (Molecular Probes), chicken antibody to GFP (Aves), rabbit antibody to Prox1 (Chemicon), rabbit antibody to Sox2 (Chemicon), mouse antibody to NeuN (Chemicon), goat antibody to DCX (Santa Cruz), mouse antibody to GST-p (BD Pharmingen), rat antibody to MBP (Serotec), rabbit antibody to NG2 (Chemicon), rabbit antibody to NF200kd (Chemicon), mouse antibody to Ascl1 (BD Pharmingen), rabbit antibody to Olig2 (Chemicon), mouse antibody to MAP2ab (Sigma), rabbit antibody to Tuj1 (Covance), mouse antibody to CNPase (Covance), mouse antibody to RIP (Hybridoma Bank), guinea pig antibody to GFAP (Advanced ImmunChemical), mouse antibody to calbindin (Swant), goat antibody to DCX (Santa Cruz) and rabbit antibody to Ki67 (Vector Laboratories). Secondary antibodies were obtained from the Jackson Laboratory.
Animals and retrovirus injections. Animal procedures were performed in accordance with protocols approved by the Institutional Animal Care Use Committee of the Salk Institute for Biological Studies. All mice used in this study were 8-11-week-old female C57Bl/6 mice (purchased from Harlan or Livermore). Mice were stereotactically injected with 1 ml of the CAG-GFP-, CAG-Ascl1-or CAG-RFP-expressing viruses, or 1.5 ml of 1:1 mixtures of CAG-GFP/CAG-RFP-and CAG-Ascl1/CAG-RFP-expressing viruses into the dentate gyrus (coordinates from bregma were -2 anterior/ posterior, ±1.5 medial/lateral and -2.3 dorsal/ventral from skull). For the experiments in the SVZ, animals were injected with a 1:1 mixture of CAG-GFP/ CAG-RFP-and CAG-Ascl1/CAG-RFP-expressing viruses (coordinates from bregma were -1 anterior/posterior, -1.0 medial/lateral and -2.8 dorsal/ventral from skull). Animals were transcardially perfused at the respective time points (group sizes, n ¼ 3). To phenotype virus-labeled cells, all GFP-expressing cells were analyzed for the expression of NeuN or oligodendrocytic markers (NG2, GST-p, MBP, Olig2 and CNPase) in separate stainings throughout the rostrocaudal extent of the dentate gyrus using a 1-in-6 series. To analyze the ratio of colabeled cells following injection of viral mixtures, we counted all virus-labeled cells again using a 1-in-6 series and formed a ratio between GFP-and RFPexpressing cells. To analyze the phenotype of virus-labeled cells 24 h, 4 d and 14 days after injection, we counted for each time point at least 20 CAG-GFPand 20 CAG-Ascl1-expressing cells.
Statistical analysis. All statistical analyses were carried out using Statview 5.0.1 (SAS). For all comparisons, ANOVA was performed, followed by Fisher's post hoc test when appropriate. Differences were considered to be statistically significant at P o 0.05.
Adult stem/progenitor cell cultures. The dentate gyrus and the SVZ of adult female rats were dissected, and progenitors were isolated and propagated as described previously 16, 45 . To determine multipotency, we treated AHPs with retinoic acid/forskolin, BMP-1/LIF or IGF-1 (refs. 44, 46) . AHPs were transduced with Ascl1-or CAG-GFP-expressing retrovirus, transferred into medium containing DMEM:F12/N2 (Sigma) without FGF-2 (ref. 16 ) and fixed 5 d after transduction. Immunostaining was carried out as described previously 44 .
Electron microscopy. Mice were transcardially perfused with 4% paraformaldehyde (wt/vol) in 0.1 M phosphate buffer, pH 7.4, at room temperature (20 ± 3 1C) for 10 min. The brain was removed 15 h after the perfusion was stopped and was postfixed for 48 h in 4% paraformaldehyde. We cut 50-mm horizontal vibratome sections, cryoprotected them in 2% glycerol and 20% DMSO (vol/vol) in 0.1 M phosphate buffer for 20 min and freeze/thawed the sections eight times in liquid nitrogen. After a treatment in 0.3% hydrogen peroxide (vol/vol, five times for 5 min each) and three 10-min washes in phosphate buffer with 0.5% bovine serum albumin (vol/vol, BSA-C, Aurion), slices were incubated overnight in the primary antibody (rabbit antibody to GFP, Chemicon) in phosphate buffer with 0.1% BSA-C at 4 1C. After washing in phosphate buffer with 0.1% BSA-C, the sections were incubated for 4 h at room temperature (20 ± 3 1C) in biotinylated secondary antibody (goat antibody to rabbit, Jackson Laboratories). To reveal this labeling, we incubated slices for 2 h in avidin biotin peroxidase complex (ABC Elite, Vector Laboratories), followed by 3,3¢-diaminobenzidine tetrachloride (Vector Laboratories Kit) for 10-20 min. The sections were then postfixed overnight in 2.5% glutaraldehyde (vol/vol), washed in 0.1 M phosphate buffer, postfixed in osmium tetroxide for 1 h, dehydrated and embedded in Epoxy resin.
Serial sections were cut at 40-nm thickness, collected on single-slot grids and contrasted by incubating for 35 min in 5% uranyl acetate solution (wt/vol), followed by 25 min in Reynolds solution. Serial images of the labeled structures were then collected with a digital camera (MegaView III, SIS) mounted on a JEOL 100 CXII transmission electron microscope at a 19,000Â magnification with a filament voltage of 80 kV.
Note: Supplementary information is available on the Nature Neuroscience website.
